Author: Lambert, Daniel W.; Hooper, Nigel M.; Turner, Anthony J.
Title: Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system Cord-id: m9tn3qu0 Document date: 2008_2_15
ID: m9tn3qu0
Snippet: Components of the renin–angiotensin system are well established targets for pharmacological intervention in a variety of disorders. Many such therapies abrogate the effects of the hypertensive and mitogenic peptide, angiotensin II, by antagonising its interaction with its receptor, or by inhibiting its formative enzyme, angiotensin-converting enzyme (ACE). At the turn of the millennium, a homologous enzyme, termed ACE2, was identified which increasingly shares the limelight with its better-kno
Document: Components of the renin–angiotensin system are well established targets for pharmacological intervention in a variety of disorders. Many such therapies abrogate the effects of the hypertensive and mitogenic peptide, angiotensin II, by antagonising its interaction with its receptor, or by inhibiting its formative enzyme, angiotensin-converting enzyme (ACE). At the turn of the millennium, a homologous enzyme, termed ACE2, was identified which increasingly shares the limelight with its better-known homologue. In common with ACE, ACE2 is a type I transmembrane metallopeptidase; however, unlike ACE, ACE2 functions as a carboxypeptidase, cleaving a single C-terminal residue from a distinct range of substrates. One such substrate is angiotensin II, which is hydrolysed by ACE2 to the vasodilatory peptide angiotensin 1–7. In this commentary we discuss the latest developments in the rapidly progressing study of the physiological and patho-physiological roles of ACE2 allied with an overview of the current understanding of its molecular and cell biology. We also discuss parallel developments in the study of collectrin, a catalytically inactive homologue of ACE2 with critical functions in the pancreas and kidney.
Search related documents:
Co phrase search for related documents- absence presence and ace inhibitor: 1
- absence presence and active site: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and acute pancreatitis: 1, 2
- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and liver fibrosis: 1
- absence presence and liver injury: 1, 2, 3, 4, 5, 6
- absence presence and lung damage: 1, 2
- absence presence and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ace action and acute ards respiratory distress syndrome: 1, 2
- ace action and acute respiratory syndrome: 1, 2, 3, 4
- ace activity and acid aspiration: 1
- ace activity and active site: 1, 2, 3, 4
- ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- ace activity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- ace activity and lung disease: 1, 2, 3
- ace activity inhibit and acute respiratory syndrome: 1
Co phrase search for related documents, hyperlinks ordered by date